Session Details

U086 Laser and Device-based Treatment of Scars

Mon, Mar 11, 7:30 AM - 8:30 AM
Room 1B
1 CME Available Focus Session
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This session will explore the use of lasers and device-based technology to treat different types of scars. Traditional and cutting-edge techniques will be explored for the correction of erythematous, pigmented, hypertrophic and atrophic scars, acne scars, burn scars, surgical scars and complex scars from trauma. Session format will include lectures and panel discussion.

LEARNING OBJECTIVES

1.

Categorize scar types.

2.

Identify new devices and techniques for treating scars.

3.

Use an algorithmic approach to choose the most appropriate therapies for different scar types.

SPEAKERS

Arielle N.B. Kauvar, MD, FAAD

Arielle N.B. Kauvar, MD, FAAD

Kristen Marie Kelly, MD, FAAD

Kristen Marie Kelly, MD, FAAD

Girish S. Munavalli, MD, MHS, FAAD

Girish S. Munavalli, MD, MHS, FAAD

Jill S. Waibel, MD, FAAD

Jill S. Waibel, MD, FAAD

SPEAKER DISCLOSURES

Arielle N.B. Kauvar, MD, FAAD

Candela Corporation – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); Sofwave – Investigator(Grants/Research Funding);

Kristen Marie Kelly, MD, FAAD

Asclepion Laser Technologies GmbH – Other(Equipment); BioPhotas Inc. – Investigator(Grants/Research Funding); Candela Corporation – Other(Equipment), Other(No Compensation Received); IQVIA – Consultant(Honoraria); Lutronic – Investigator(Equipment), Investigator(Grants/Research Funding); NobelPharma – Consultant (1099 relationship)(Honoraria); Orlucent – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); R2 Dermatology, Inc. – Investigator(Equipment); Reliant Technologies, Inc. – Other(Equipment); Sciton, Inc. – Consultant(Honoraria), Speaker(Honoraria); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Thermage – Other(Equipment); Vivosight – Consultant (1099 relationship)(Equipment), Consultant (1099 relationship)(Grants/Research Funding);

Girish S. Munavalli, MD, MHS, FAAD

Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);

Jill S. Waibel, MD, FAAD

Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);